Retinal toxicity to antimalarial drugs: Chloroquine and hydroxychloroquine: A neurophysiologic study

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 377-383

  Farrell, Donald F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Autofluorescence; Chloroquine; Hydroxychloroquine; Multifocal electroretinogram (mfERG); Spectral domain optical coherence tomography (SD OCT)

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

ADULT; AGE; AGED; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; COMPUTER ASSISTED PERIMETRY; CORNEAL FULL FIELD FLASH ELECTRORETINOGRAM; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DRUG EXPOSURE; ELECTRORETINOGRAM; EYE TOXICITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MULTIFOCAL ELECTRORETINOGRAM; NEUROPHYSIOLOGY; OPHTHALMOSCOPY; RETINAL TOXICITY; SENSITIVITY ANALYSIS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TERTIARY HEALTH CARE; TREATMENT DURATION;

EID: 84859526668     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S27731     Document Type: Article

References (17)

1. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthmalology. 2011;118(2):415-422.
2. Farrell DF. Unilateral retinitis pigmentosa and cone-rod dystrophy. Clin Ophthalmol. 2009;3:263-270.
3. Grendahl J. Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet. 1987;31(4):255-264.
4. Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick YH. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 1984;97(3): 357-365.
5. Sen P, Bhargave A, George R, et al. Prevalence of retinitis pigmentosa in South Indian population aged above 40 years. Ophthalmic Epidemiol. 2008;15(4):279-281.
6. Tzekow R. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol. 2005;110(1):111-120.
7. Lawrence JS. Prevalence of rheumatoid arthritis. Ann Rheum Dis. 1961; 20:11-17.
8. Symmons D, Turner C, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford). 2002;41(7):793-800.
9. Peschken CA, Esdale JM. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol. 2000;27(8): 1884-1891.
10. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol. 1985;14(1):43-46.
11. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37:1069-1076.
12. Nebbioso M, Grenga R, Karavitis P. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy. J Ocul Pharmacol Ther. 2009;25(3):249-258.
13. Lai TY, Ngai JW, Chan WM, Lam DS. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol. 2006;112(3):177-187.
14. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. A novel method for screening the multifocal electroretinogram in patients using hydroxychloroquine. Retina. 2008;28:1478-1486.
15. Chen E, Brown DM, Benz MS, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clin Ophthmalmol. 2010;4: 1151-1158.
16. Kellner U, Renner AR, Tillack H. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/ hydroxychloroquine. Invest Ophthalmol Vis Sci. 2006;47(8): 3531-3538.
17. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci. 1978;17(12):1158-1175.